Frequently Asked Questions
The market is segmented based on Global Next Generation Sequencing (NGS) Market Segmentation, By Product and Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2032
.
The Global Next Generation Sequencing Ngs Market size was valued at USD 15.98 USD Billion in 2024.
The Global Next Generation Sequencing Ngs Market is projected to grow at a CAGR of 15.1% during the forecast period of 2025 to 2032.
The major players operating in the market include IlluminaInc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation. AGilent TechnologiesInc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta USInc., Beckman CoulterInc., Bio-Rad LaboratoriesInc., PacBio., MacrogenInc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. .
The market report covers data from the North America.
